Sahil Dhingra
Analyst
RBC
Equibles does not estimate personal net worth.
About Sahil Dhingra
Sahil Dhingra is recorded as Analyst at RBC. Sahil Dhingra has spoken on 3 earnings calls across 1 company, most recently for Ligand Pharmaceuticals Inc on August 6, 2026. The companies whose calls Sahil Dhingra spoke on are classified in the Healthcare sector.
Sahil Dhingra on recent calls
“My first question is related to the $2.3 billion of potential milestone opportunities from the Zoma portfolio. Can you frame for us the probability where they're near to value?”
“My first question is on the capital performance in the quarter, which was down year over year. What gives you confidence in achieving the full year capital guidance?”
“My first question is related to the competition. Have you seen any changes in the competitive landscape for royalty asset as it relates to either on-the-market products or products that are in clinical stage?”
Affiliation history
-
RBC
Analyst
Transcript header (unverified)
Current